{"id":12796,"date":"2024-10-11T15:39:06","date_gmt":"2024-10-11T13:39:06","guid":{"rendered":"https:\/\/valintermed.com\/?p=12796"},"modified":"2024-10-11T15:39:06","modified_gmt":"2024-10-11T13:39:06","slug":"retinalnaya-vaskulopatiya-s-tserebralnoy-leykodistrofiey","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/retinal-vasculopathy-with-cerebral-leukodystrophia\/","title":{"rendered":"Retinal vasculopathy with cerebral leukodystrophy"},"content":{"rendered":"<div class=\"fpm_start\"><\/div>\n<p>Retinal vasculopathy with cerebral leukodystrophy is a rare disorder characterized by abnormalities in the retinal vessels and demyelinating changes in the white matter of the brain. These conditions are usually associated with various genetic, metabolic, and vascular abnormalities. Retinal vasculopathy occurs at the retinal level and can lead to changes in vision, while cerebral leukodystrophy affects the nervous tissue, leading to deterioration of mental and physical functions. The diseases can be idiopathic or associated with certain syndromes, which significantly complicates the diagnosis and treatment process.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_83 counter-flat ez-toc-counter ez-toc-light-blue ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Content<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 eztoc-toggle-hide-by-default' ><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/retinal-vasculopathy-with-cerebral-leukodystrophia\/#%D0%98%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%8F_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%B8_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B5%D1%81%D0%BD%D1%8B%D0%B5_%D0%B8%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D1%84%D0%B0%D0%BA%D1%82%D1%8B\" >History of the disease and interesting historical facts<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/retinal-vasculopathy-with-cerebral-leukodystrophia\/#%D0%AD%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F\" >Epidemiology<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/retinal-vasculopathy-with-cerebral-leukodystrophia\/#%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%80%D0%B0%D1%81%D0%BF%D0%BE%D0%BB%D0%BE%D0%B6%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C_%D0%BA_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%BC%D1%83_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8E\" >Genetic predisposition to this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/retinal-vasculopathy-with-cerebral-leukodystrophia\/#%D0%A4%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D1%8B_%D1%80%D0%B8%D1%81%D0%BA%D0%B0_%D0%B2%D0%BE%D0%B7%D0%BD%D0%B8%D0%BA%D0%BD%D0%BE%D0%B2%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Risk factors for the development of this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/retinal-vasculopathy-with-cerebral-leukodystrophia\/#%D0%94%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Diagnosis of this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/retinal-vasculopathy-with-cerebral-leukodystrophia\/#%D0%9B%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5\" >Treatment<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/retinal-vasculopathy-with-cerebral-leukodystrophia\/#%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D1%8B%D1%85_%D0%B4%D0%BB%D1%8F_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >List of medications used to treat this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/retinal-vasculopathy-with-cerebral-leukodystrophia\/#%D0%9C%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Disease monitoring<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/retinal-vasculopathy-with-cerebral-leukodystrophia\/#%D0%92%D0%BE%D0%B7%D1%80%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B5_%D0%BE%D1%81%D0%BE%D0%B1%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Age-related features of the disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/retinal-vasculopathy-with-cerebral-leukodystrophia\/#%D0%92%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%8B_%D0%B8_%D0%BE%D1%82%D0%B2%D0%B5%D1%82%D1%8B\" >Questions and Answers<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"%D0%98%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%8F_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%B8_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B5%D1%81%D0%BD%D1%8B%D0%B5_%D0%B8%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D1%84%D0%B0%D0%BA%D1%82%D1%8B\"><\/span>History of the disease and interesting historical facts<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The first mentions of retinal vasculopathy and cerebral leukodystrophy date back to the early 20th century, when modern imaging techniques and description of pathological changes became available. In the 1920s, when doctors managed to establish a connection between changes in the retina and pathologies of the central nervous system, an attempt was made to classify such conditions. In the 1940s, the hereditary nature of some forms of leukodystrophies became known, which led to further studies of the genetic basis of these diseases. Interestingly, retinal vascular pathologies began to be studied in the context of systemic diseases such as diabetes and hypertension, which made it possible to establish a relationship with cerebral pathology.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%AD%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F\"><\/span>Epidemiology<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The epidemiology of retinal vasculopathy and cerebral leukodystrophy remains poorly understood due to the rarity of these conditions. According to various sources, the prevalence of leukodystrophies varies from 1 in 100,000 to 1 in 1,000,000 cases, depending on the genetic type and risk factors. Retinal vasculopathy is more common, especially in patients with systemic diseases such as diabetic retinopathy, but accurate statistics on the combination of these disorders are extremely limited. A 2020 study from one of the universities showed that 15% patients with retinal vasculopathy had symptoms suggestive of cerebral leukodystrophy.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%80%D0%B0%D1%81%D0%BF%D0%BE%D0%BB%D0%BE%D0%B6%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C_%D0%BA_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%BC%D1%83_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8E\"><\/span>Genetic predisposition to this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Genetic predisposition to retinal vasculopathy with cerebral leukodystrophy is expressed through specific mutations in genes responsible for the structure and function of blood vessels and the myelin sheath of nerve fibers. Examples of genes involved include:<\/p>\n<ul>\n<li>specific mutations in the NOTCH3 gene associated with hereditary vasopathy;<\/li>\n<li>FTL gene mutations associated with iron metabolism disorders;<\/li>\n<li>genes responsible for myelin synthesis, such as MAG and MBP, associated with leukodystrophies;<\/li>\n<li>variants of genes involved in lipid metabolism and vascular regeneration.<\/li>\n<\/ul>\n<p>These mutations can lead to endothelial dysfunction and myelination failure, which ultimately causes the clinical manifestations of these diseases. Understanding the genetic component is necessary for early diagnosis and the possibility of genetic counseling.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A4%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D1%8B_%D1%80%D0%B8%D1%81%D0%BA%D0%B0_%D0%B2%D0%BE%D0%B7%D0%BD%D0%B8%D0%BA%D0%BD%D0%BE%D0%B2%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Risk factors for the development of this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Risk factors that contribute to the development of retinal vasculopathy and cerebral leukodystrophy include both genetic and external circumstances:<\/p>\n<ul>\n<li>presence of hereditary diseases in the family;<\/li>\n<li>high blood pressure, which contributes to changes in the vascular bed;<\/li>\n<li>diabetes, which can affect the blood vessels in the retina;<\/li>\n<li>bad habits, such as smoking, which have a negative impact on the condition of blood vessels;<\/li>\n<li>age-related changes leading to general vascular pathology.<\/li>\n<li>exposure to toxic substances such as lead or mercury, which impair neuronal function.<\/li>\n<\/ul>\n<p>These factors significantly increase the risk of developing diseases, which requires attention from medical professionals at the stage of prevention and diagnosis.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%94%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Diagnosis of this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The diagnosis of retinal vasculopathy with cerebral leukodystrophy is based on clinical evaluation, laboratory tests, and imaging studies. The main symptoms to look for include:<\/p>\n<ul>\n<li>loss of vision or its deterioration;<\/li>\n<li>neurological symptoms such as weakness or numbness;<\/li>\n<li>long-term cognitive impairment.<\/li>\n<\/ul>\n<p>Laboratory tests may include complete blood counts for inflammatory markers and biochemical panels. Radiologic tests, such as MRI of the brain, may help visualize white matter changes characteristic of leukodystrophies. Other diagnostic tests may include ophthalmoscopy to evaluate the retinal vessels. The differential diagnosis requires ruling out other causes of vascular and myelin damage, such as vascular diseases or infections.<\/p><script data-noptimize=\"\" data-wpfc-render=\"false\">\nfpm_start( \"true\" );\n<\/script>\n\n<h2><span class=\"ez-toc-section\" id=\"%D0%9B%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5\"><\/span>Treatment<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Treatment of retinal vasculopathy with cerebral leukodystrophy is multi-level and includes both drug and non-drug approaches. General treatment is aimed at managing symptoms and improving quality of life. Pharmacological treatment may include:<\/p>\n<ul>\n<li>anticoagulants to improve blood circulation;<\/li>\n<li>nonsteroidal anti-inflammatory drugs to reduce inflammation;<\/li>\n<li>neuroprotectors to support neuronal function;<\/li>\n<li>vitamin and mineral complexes to improve metabolism.<\/li>\n<\/ul>\n<p>Surgical treatment may be considered in cases where acute vascular complications need to be addressed. Other treatments, such as physical therapy and speech therapy, may also be included in the rehabilitation program.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D1%8B%D1%85_%D0%B4%D0%BB%D1%8F_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>List of medications used to treat this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Drugs used in the treatment of retinal vasculopathy and cerebral leukodystrophy may include, but are not limited to, the following:<\/p>\n<ul>\n<li>Aspirin (anticoagulant);<\/li>\n<li>Clopidogrel;<\/li>\n<li>Dextromethorphan (neuroprotector);<\/li>\n<li>B vitamins;<\/li>\n<li>Nonsteroidal anti-inflammatory drugs (eg, Ibuprofen).<\/li>\n<\/ul>\n<p>These drugs can be prescribed either individually or in combination depending on the clinical situation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%9C%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Disease monitoring<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Monitoring of patients with retinal vasculopathy and cerebral leukodystrophy requires regular follow-up to assess the stability of the condition and identify possible complications. The prognosis may vary depending on the severity and form of the disease: from a stable condition to significant deterioration with the development of disability. Complications may include progression of neurological symptoms, deterioration of vision, and an increased risk of stroke.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%92%D0%BE%D0%B7%D1%80%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B5_%D0%BE%D1%81%D0%BE%D0%B1%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Age-related features of the disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Age-related features of the course of retinal vasculopathy with cerebral leukodystrophy depend on the clinical form of the disease. In children, the disease often occurs with neurological manifestations, while in the elderly, deterioration of the vascular system is observed. In the elderly, the vascular component predominates and their condition requires special attention to the correction of concomitant diseases, such as arterial hypertension and diabetes.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%92%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%8B_%D0%B8_%D0%BE%D1%82%D0%B2%D0%B5%D1%82%D1%8B\"><\/span>Questions and Answers<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>What is retinal vasculopathy?<\/strong> This is a disease characterized by damage to the blood vessels in the retina, which can lead to deterioration of vision.<\/li>\n<li><strong>What is the cause of cerebral leukodystrophy?<\/strong> The causes can be varied, including genetic mutations and metabolic disorders.<\/li>\n<li><strong>What symptoms indicate the presence of these diseases?<\/strong> The main symptoms include vision loss, numbness, weakness and possible cognitive impairment.<\/li>\n<li><strong>Treatment methods for this pathology?<\/strong> Treatment may include medications, physical therapy, and, in some cases, surgery.<\/li>\n<li><strong>How is diagnostics carried out?<\/strong> Diagnostics includes ophthalmological and neurological examinations, laboratory and imaging methods.<\/li>\n<\/ul>\n<p>This article explains important aspects of retinal vasculopathy with cerebral leukodystrophy, including its manifestations, diagnosis, and treatment, to enable physicians and patients to more effectively manage these diseases.<\/p>\n<div class=\"fpm_end\"><\/div>","protected":false},"excerpt":{"rendered":"<p>Retinal vasculopathy with cerebral leukodystrophy is a rare combination of diseases characterized by disorders in the retinal vessels and demyelinating changes.<\/p>","protected":false},"author":1,"featured_media":22594,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[298],"tags":[],"class_list":["post-12796","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medlibrary"],"_links":{"self":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/12796","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/comments?post=12796"}],"version-history":[{"count":1,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/12796\/revisions"}],"predecessor-version":[{"id":14285,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/12796\/revisions\/14285"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/media\/22594"}],"wp:attachment":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/media?parent=12796"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/categories?post=12796"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/tags?post=12796"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}